The VEGFR-2 protein and the VEGFR-2 rs1870377 A>T genetic polymorphism are prognostic factors for gastric cancer

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262.
   PubMed Web of Science ®Google Scholar
• Folli S, Dente M, Dell’Amore D, Gaudio M, Nanni O, Saragoni L, Vio A. Early gastric cancer: prognostic factors in 223 patients. Br J Surg. 1995;82(7):952–956.
   PubMed Web of Science ®Google Scholar
• Baeriswyl V, Christofori G. The angiogenic switch in carcinogenesis. Semin Cancer Biol. 2009;19(5):329–337. doi:10.1016/j.semcancer.2009.05.003.
   PubMed Web of Science ®Google Scholar
• Kappas NC, Zeng G, Chappell JC, Kearney JB, Hazarika S, Kallianos KG, Patterson C, Annex BH, Bautch VL. The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. J Cell Biol. 2008;181(5):847–858. doi:10.1083/jcb.200709114.
   PubMed Web of Science ®Google Scholar
• Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res. 2006;312(5):549–560. doi:10.1016/j.yexcr.2005.11.012.
   PubMed Web of Science ®Google Scholar
• Goel HL, Mercurio AM. VEGF targets the tumour cell. Nat Rev Cancer. 2013;13(12):871–882. doi:10.1038/nrc3627.
   PubMed Web of Science ®Google Scholar
• Yan JD, Liu Y, Zhang ZY, Liu GY, Xu JH, Liu LY, Hu YM. Expression and prognostic significance of VEGFR-2 in breast cancer. Pathol Res Pract. 2015;211(7):539–543. doi:10.1016/j.prp.2015.04.003.
   PubMed Web of Science ®Google Scholar
• Hirashima Y, Yamada Y, Matsubara J, Takahari D, Okita N, Takashima A, Kato K, Hamaguchi T, Shirao K, Shimada Y, et al. Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer. Cancer Sci. 2009;100(2):310–315. doi:10.1111/j.1349-7006.2008.01020.x.
   PubMed Web of Science ®Google Scholar
• Kowanetz M, Ferrara N. Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clinl Cancer Res: off J Am Assoc Cancer Res. 2006;12(17):5018–5022. doi:10.1158/1078-0432.CCR-06-1520.
   PubMed Web of Science ®Google Scholar
• Hsu J-T, Chen T-D, Chuang H-C, Huang S-C, Le P-H, Chen T-H, Lin C-J, Yeh T-S. Vascular endothelial growth factor expression is an independent poor prognostic factor for human epidermal growth factor receptor 2 positive gastric cancer. J Surg Res. 2017;208:40–50. doi:10.1016/j.jss.2016.09.004.
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285(21):1182–1186. doi:10.1056/NEJM197111182852108.
   PubMed Web of Science ®Google Scholar
• Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science (New York, NY). 1989;246(4935):1306–1309. doi:10.1126/science.2479986.
   Google Scholar
• Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol. 2009;21(2):154–165. doi:10.1016/j.ceb.2008.12.012.
   PubMed Web of Science ®Google Scholar
• Su JL, Yang PC, Shih JY, Yang CY, Wei LH, Hsieh CY, Chou CH, Jeng YM, Wang MY, Chang KJ, et al. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell. 2006;9(3):209–223. doi:10.1016/j.ccr.2006.02.018.
   PubMed Web of Science ®Google Scholar
• Hansen TF, Sorensen FB, Spindler KL, Olsen DA, Andersen RF, Lindebjerg J, Brandslund I, Jakobsen A. Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer. Virchows Archiv: int j pathol. 2010;456(3):251–260. doi:10.1007/s00428-009-0878-8.
   PubMed Web of Science ®Google Scholar
• Jurgensmeier JM, Schmoll HJ, Robertson JD, Brooks L, Taboada M, Morgan SR, Wilson D, Hoff PM. Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy. Br J Cancer. 2013;108(6):1316–1323. doi:10.1038/bjc.2013.79.
   PubMed Web of Science ®Google Scholar
• Liu X, Li Y, Wei J, Zhao Y. Role of Ang-2, Tie-2 and VEGFR-2 in angiogenesis in colorectal carcinoma and their prognostic value. Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University. 2012;32(11):1658–1662.
   PubMedGoogle Scholar
• Chatterjee S, Heukamp LC, Siobal M, Schottle J, Wieczorek C, Peifer M, Frasca D, Koker M, Konig K, Meder L, et al. Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer. J Clin Invest. 2013;123(4):1732–1740. doi:10.1172/JCI65385.
   PubMed Web of Science ®Google Scholar
• Scartozzi M, Loretelli C, Galizia E, Mandolesi A, Pistelli M, Bittoni A, Giampieri R, Faloppi L, Bianconi M, Del Prete M, et al. Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients. PloS one. 2012;7(7):e38192. doi:10.1371/journal.pone.0038192.
   PubMed Web of Science ®Google Scholar
• Maeng CH, Yi JH, Lee J, Hong JY, Choi MK, Jung HA, Park JO, Park SH, Park YS, Kang WK, et al. Effects of single nucleotide polymorphisms on treatment outcomes and toxicity in patients treated with sunitinib. Anticancer Res. 2013;33(10):4619–4626.
   PubMed Web of Science ®Google Scholar
• Kim JG, Sohn SK, Chae YS, Cho YY, Bae HI, Yan G, Park JY, Lee MH, Chung HY, Yu W. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer. Ann Oncology: Official Journal Eur Soc Med Oncol. 2007;18(6):1030–1036. doi:10.1093/annonc/mdm085.
   PubMed Web of Science ®Google Scholar
• Allele: NM_002253.2(KDR): c.146 A > T (p.Gln472His). allele ID: 138342, variant type: single nucleotide variant. https://www.ncbi.nlm.nih.gov/clinvar/variation/134603/.
   Google Scholar